RECENT NEWS

A team of researchers from UCLA has introduced a deep learning-enhanced, paper-based vertical flow assay (VFA) capable of detecting cardiac troponin I (cTnI) with high sensitivity. The innovative assay holds the potential to democratise access to rapid and reliable cardiac diagnostics, particularly in resource-limited settings.

A nationwide team of universities, hospitals and industry led by the Francis Crick Institute and The Royal Marsden NHS Foundation Trust, have launched a new platform to understand immunotherapy response and side effects in cancer, with the National Pathology Imaging Co-operative playing a critical role.

Proteotype Diagnostics Ltd, in collaboration with the University of Southampton, has been awarded £1.5 million in funding from the National Institute for Health and Care Research (NIHR) and the Office for Life Sciences (OLS). The grant will support clinical validation of Proteotype's novel Enlighten multi-cancer early detection test, a revolutionary approach to detecting early-stage cancers by focusing on the body's response to tumour development.

A new partnership between Roche Diagnostics UK and Ireland, Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, will play a key role in developing cutting-edge medical diagnostics.

The National Institute for Health and Care Research (NIHR) has announced almost £11 million of new funding for projects which aim to help increase the early detection and diagnosis of cancer.

The Royal College of Pathologists (RCPath) is marking International Pathology Day this year on Wednesday 6 November with a day-long virtual conference looking at the issue of antimicrobial resistance (AMR).

The final stages of recovery following the cyber attack on pathology services provider Synnovis in June are almost complete, which means nearly all services are now up and running.

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched its ambitious new business plan for 2024/25, setting out the agency’s core focus of enabling access to innovative healthcare products while ensuring delivery for all who need its services – patients and the public, healthcare professionals, researchers and developers.

Italian microsopy manufacturer CrestOptics and Leica Microsystems have announced a new collaboration, bringing CrestOptics’ CICERO spinning disk unit technology to Leica Microsystems’ new THUNDER Imager Cell Spinning Disk system.

Netherlands-based diagnostic firm QIAGEN has announced the launch of the QIAcuityDx Digital PCR System, a new addition to its digital PCR portfolio which is expanding into clinical diagnostics. The new system streamlines clinical testing by providing highly precise, absolute quantitation of target DNA and RNA, supporting applications with less invasive liquid biopsies.

Clinicians working at five of the six NHS Trusts in the West Yorkshire Association of Acute Trusts (WYAAT) can access pathology and other diagnostic test results from across their network, following a summer roll-out of Clinisys’ ICE OpenNet.

Digital pathology firm Proscia has announced the launch of Concentriq Embeddings and the Proscia AI Toolkit, enabling life sciences organisations to accelerate the discovery and development of novel therapies and diagnostics.

Hundreds of babies have begun to be tested for over 200 rare genetic conditions as part of a world-leading study in NHS hospitals that aims to screen up to 100,000 newborns in England.

Beckman Coulter Life Sciences has announced the appointment of Joe Fox as President of the company, effective immediately.

A new white paper report commissioned by Abbott seeks to provide a constructive contribution to ongoing policy and legislative developments for medical devices and diagnostics. Its release comes as the new UK Government looks to refocus healthcare more towards prevention and closer to home through the use of the latest innovative technologies, and with a focus on regulatory innovation.

Research led by scientists at Queen Mary University of London is heralding in a new era for genetic sequencing and testing.

BioAI, a biotechnology company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic partnership with Arbele, a biopharmaceutical company dedicated to developing novel immunotherapeutic platforms for gastrointestinal cancers.

A collaborative research team led by Professor Chulhong Kim and Professor Chan Kwon Jung of Seoul St. Mary’s Hospital, Catholic University of Korea, has developed an artificial intelligence (AI) system to analyse the label-free photoacoustic histological images of human liver cancer tissues.

AI-powered pathology solutions provider Mindpeak has announced it has raised $15.3 million in a Series A funding round. This new investment will enable the company to further expand the commercialisation of its recently expanded suite of technologies across several new territories.

‘Breath biopsy’ firm Owlstone Medical has announced it has entered into a Research Collaboration Agreement with the US FDA’s Center for Devices and Radiological Health (CDRH) - Office of Science and Engineering Laboratories (OSEL). The goal of the collaboration is to develop methods for the confident identification of individual chemicals in the complex mixture of breath.